系统性红斑狼疮患者Th17相关4种细胞因子的研究

严瑾, 胡丽华. 系统性红斑狼疮患者Th17相关4种细胞因子的研究[J]. 临床血液学杂志, 2017, 30(12): 913-916. doi: 10.13201/j.issn.1004-2806-b.2017.12.004
引用本文: 严瑾, 胡丽华. 系统性红斑狼疮患者Th17相关4种细胞因子的研究[J]. 临床血液学杂志, 2017, 30(12): 913-916. doi: 10.13201/j.issn.1004-2806-b.2017.12.004
YAN Jin, HU Lihua. Study of four cytokines related to Th17 cells in patients with systemic lupus erythematosus[J]. J Clin Hematol, 2017, 30(12): 913-916. doi: 10.13201/j.issn.1004-2806-b.2017.12.004
Citation: YAN Jin, HU Lihua. Study of four cytokines related to Th17 cells in patients with systemic lupus erythematosus[J]. J Clin Hematol, 2017, 30(12): 913-916. doi: 10.13201/j.issn.1004-2806-b.2017.12.004

系统性红斑狼疮患者Th17相关4种细胞因子的研究

详细信息
    通讯作者: 胡丽华,E-mail:xhhulh@126.com
  • 中图分类号: R593.24

Study of four cytokines related to Th17 cells in patients with systemic lupus erythematosus

More Information
  • 目的:研究Th17相关的4种细胞因子IL-17,IL-21,IL-22,IL-23在系统性红斑狼疮(SLE)患者与健康人群中血清含量的差别和SLE患者血清中这4种细胞因子的含量与实验室检查指标的关联。方法:收集65例SLE患者和36例健康体检者的血清,用酶联免疫吸附试验(ELISA)检测2组样本血清中Th17细胞相关的4种细胞因子IL-17,IL-21,IL-22,IL-23的含量,将SLE患者与健康人群血清中4种细胞因子的含量进行对比,观察两者之间的差异性;将SLE患者血清中这4种细胞因子的含量与实验室指标进行比较,观察其相关性。采用SPSS19.0进行统计分析。结果:SLE患者血清中IL-17和IL-21的含量显著高于正常对照组(P<0.01),SLE患者血清中IL-22 和IL-23的水平相对于正常组差异无统计学意义;65例SLE患者血清抗-dsDNA抗体,抗核小体,抗组蛋白阳性组与阴性组比较,阳性组IL-17含量均显著增高(P<0.05);相反,抗-Sm抗体阳性组与阴性组比较,阳性组IL-17含量显著降低(P<0.05);65例SLE患者血清中的IL-17,IL-21含量与C3含量之间均有显著关联(P<0.05),而这4种细胞因子与IgG含量无关联。结论:SLE患者血清里Th17相关细胞因子IL-17,IL-21 的升高可能促进了疾病的发生与发展;通过对4种细胞因子含量与实验室指标的关联分析,说明IL-17可能促进了SLE患者体内抗-dsDNA抗体,抗核小体,抗组蛋白等的分泌,同时也说明IL-17含量的高低可能对SLE患者疾病的严重程度有一定的提示作用。
  • 加载中
  • [1]

    戴超,李向培.系统性红斑狼疮Th17细胞分子调控机制研究进展[J].安徽医药,2016,20(5):817-820.

    [2]

    Yang J, Yang X, Zou H,et al.Recovery of the immune balance between Th17 and regulatory T cells as a treatment for systemic lupuserythematosus[J]. Rheumatology,2011,50:1366-72.

    [3]

    Rother, N.van der Vlag, J.Disturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus Erythematosus[J]. Front Immunol,2015,6:610.

    [4]

    Júlio Antônio Pereira Araújo a, DaniloMesquitaJr a, Wilson de MeloCruvinel a, et al.Th17 cells and CD4+ multifunctional T cells in patients with systemic lupus erythematosus[J]. Rev Bras Reumatol Engl Ed,2016,56:28-36.

    [5]

    Robak E, Kulczycka-Siennicka L, Gerlicz Z, et al. Correlations between concentrations of interleukin (IL)-17A,IL-17B and IL-17F, and endothelial cells and proangiogenic cytokines in systemic lupus erythematosus patients[J]. Eur Cytokine Network,2013,24:60-68.

    [6]

    Wang HX, Chu S1, Li J, et al. Increased IL-17 and IL-21 producing TCRαβ+CD4-CD8- T cells in Chinese systemic lupus erythematosus patients[J]. Lupus, 2014,23:643-54.

    [7]

    蓝艳,郭静.白细胞介素-21与系统性红斑狼疮之关系研究进展[J].分子诊断与治疗杂志,2015,7(2):127-131.

    [8]

    Karrich JJ, Jachimowski LC, Nagasawa M, et al. IL-21stimulated human plasmacytoid dendritic cells secretegranzyme B, which impairs their capacity to induce T-cell proliferation[J]. Blood, 2013,121:3103-3111.

    [9]

    Blom L, Poulsen LK. In vitro Th1 and Th2 cell polarization is severely influenced by the initial ratio of naive and memory CD4+T cells[J]. Immunol Methods, 2013,397:55-60.

    [10]

    鄢海波,赵令,马宁.汉族人系统性红斑狼疮和狼疮肾炎与IL-22受体基因多态性的关系[J].中国现代医学杂志,2017,27(9):44-48.

    [11]

    Amarilyo G,Lourenco EV,Shi FD,et al.IL-17 promotes murine lupus[J].J Immunol,2014,193:540-543.

  • 加载中
计量
  • 文章访问数:  399
  • PDF下载数:  0
  • 施引文献:  0
出版历程
收稿日期:  2017-08-30

目录